Evidence map›Paper›PMID 31011552›Full record

ArticleAdvanced pharmaceutical bulletin2019

Metformin: Ongoing Journey with Superdrug Revolution.

Amr Ahmed El-Arabey, Mohnad Abdalla, Wafa Ali Eltayb

Abstract read
In one paragraph

Article in Advanced pharmaceutical bulletin, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Metformin suppresses proliferation and glycolysis of gastric cancer by modulating ADAMTS12.Genes and environment : the official journal of the Japanese Environmental Mutagen Society · 2024
    Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Metabolic syndrome and male fertility disorders: Is there a causal link?Reviews in endocrine & metabolic disorders · 2021
    Review
  14. Article
  15. Observational
  16. Article
  17. Article
  18. Metformin and COVID-19: A novel deal of an old drug.Journal of medical virology · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Amr Ahmed El-ArabeyPharmacology and Toxicology Department, Faculty of Pharmacy, Al-Azhar University, Egypt.ORCID https://orcid.org/0000-0003-0420-7191
Mohnad AbdallaQingdao Institute of Bioenergy and Bioprocess Technology, Qingdao Shi, Shandong Sheng 266000, People's Republic of China.
Wafa Ali EltaybFaculty of Science and Technology, Shendi University, Shendi, Nher Anile, Sudan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID31011552
PMCPMC6468224

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.